OpenURL Connection Search

Select item for more details and to access through your institution.

Efficacy of radiotherapy for primary tumor in patients with unresectable pancreatic neuroendocrine tumors.
Published in:
Japanese Journal of Clinical Oncology, 2017, v. 47, n. 9, p. 826, doi. 10.1093/jjco/hyx081
By:
- Tomoyuki Iwata;
- Hideki Ueno;
- Jun Itami;
- Yoshinori Ito;
- Koji Inaba;
- Chigusa Morizane;
- Shunsuke Kondo;
- Yasunari Sakamoto;
- Satoshi Shiba;
- Mitsuhito Sasaki;
- Futa Koga;
- Takuji Okusaka
Publication type:
Article
C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-34962-7
By:
- Shirakawa, Tsuyoshi;
- Makiyama, Akitaka;
- Shimokawa, Mototsugu;
- Otsuka, Taiga;
- Shinohara, Yudai;
- Koga, Futa;
- Ueda, Yujiro;
- Nakazawa, Junichi;
- Otsu, Satoshi;
- Komori, Azusa;
- Arima, Shiho;
- Fukahori, Masaru;
- Taguchi, Hiroki;
- Honda, Takuya;
- Shibuki, Taro;
- Nio, Kenta;
- Ide, Yasushi;
- Ureshino, Norio;
- Mizuta, Toshihiko;
- Mitsugi, Kenji
Publication type:
Article
Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatment: results from the NAPOLEON study.
Published in:
International Journal of Clinical Oncology, 2023, v. 28, n. 8, p. 1073, doi. 10.1007/s10147-023-02354-6
By:
- Komori, Azusa;
- Otsu, Satoshi;
- Shimokawa, Mototsugu;
- Otsuka, Taiga;
- Koga, Futa;
- Ueda, Yujiro;
- Nakazawa, Junichi;
- Arima, Shiho;
- Fukahori, Masaru;
- Okabe, Yoshinobu;
- Makiyama, Akitaka;
- Taguchi, Hiroki;
- Honda, Takuya;
- Shibuki, Taro;
- Nio, Kenta;
- Ide, Yasushi;
- Ureshino, Norio;
- Mizuta, Toshihiko;
- Shirakawa, Tsuyoshi;
- Mitsugi, Kenji
Publication type:
Article
Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.
Published in:
2021
By:
- Otsuka, Taiga;
- Shirakawa, Tsuyoshi;
- Shimokawa, Mototsugu;
- Koga, Futa;
- Kawaguchi, Yasunori;
- Ueda, Yujiro;
- Nakazawa, Junichi;
- Komori, Azusa;
- Otsu, Satoshi;
- Arima, Shiho;
- Fukahori, Masaru;
- Okabe, Yoshinobu;
- Makiyama, Akitaka;
- Taguchi, Hiroki;
- Honda, Takuya;
- Shibuki, Taro;
- Nio, Kenta;
- Ide, Yasushi;
- Mizuta, Toshihiko;
- Mitsugi, Kenji
Publication type:
Correction Notice
A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.
Published in:
International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 941, doi. 10.1007/s10147-021-01859-2
By:
- Otsuka, Taiga;
- Shirakawa, Tsuyoshi;
- Shimokawa, Mototsugu;
- Koga, Futa;
- Kawaguchi, Yasunori;
- Ueda, Yujiro;
- Nakazawa, Junichi;
- Komori, Azusa;
- Otsu, Satoshi;
- Arima, Shiho;
- Fukahori, Masaru;
- Okabe, Yoshinobu;
- Makiyama, Akitaka;
- Taguchi, Hiroki;
- Honda, Takuya;
- Shibuki, Taro;
- Nio, Kenta;
- Ide, Yasushi;
- Mizuta, Toshihiko;
- Mitsugi, Kenji
Publication type:
Article
Autopsy case of systemic EBV-positive T-cell lymphoma of childhood with marked hepatomegaly in a middle-aged man.
Published in:
Pathology International, 2017, v. 67, n. 8, p. 431, doi. 10.1111/pin.12549
By:
- Kai, Keita;
- Koga, Futa;
- Araki, Norimasa;
- Shindo, Takero;
- Eguchi, Yuichiro;
- Toda, Shuji;
- Aishima, Shinichi
Publication type:
Article
Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxel.
Published in:
Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65689-8
By:
- Shibuki, Taro;
- Otsuka, Taiga;
- Shimokawa, Mototsugu;
- Nakazawa, Junichi;
- Arima, Shiho;
- Fukahori, Masaru;
- Miwa, Keisuke;
- Okabe, Yoshinobu;
- Koga, Futa;
- Ueda, Yujiro;
- Kubotsu, Yoshihito;
- Makiyama, Akitaka;
- Shimokawa, Hozumi;
- Takeshita, Shigeyuki;
- Nishikawa, Kazuo;
- Komori, Azusa;
- Otsu, Satoshi;
- Hosokawa, Ayumu;
- Sakai, Tatsunori;
- Oda, Hisanobu
Publication type:
Article
A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer.
Published in:
Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-63172-y
By:
- Kodama, Tomoko;
- Imajima, Takashi;
- Shimokawa, Mototsugu;
- Otsuka, Taiga;
- Kawahira, Masahiro;
- Nakazawa, Junichi;
- Hori, Takeshi;
- Shibuki, Taro;
- Arima, Shiho;
- Ido, Akio;
- Miwa, Keisuke;
- Okabe, Yoshinobu;
- Koga, Futa;
- Ueda, Yujiro;
- Kubotsu, Yoshihito;
- Shimokawa, Hozumi;
- Takeshita, Shigeyuki;
- Nishikawa, Kazuo;
- Komori, Azusa;
- Otsu, Satoshi
Publication type:
Article
Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study).
Published in:
2022
By:
- Shibuki, Taro;
- Mizuta, Toshihiko;
- Shimokawa, Mototsugu;
- Koga, Futa;
- Ueda, Yujiro;
- Nakazawa, Junichi;
- Komori, Azusa;
- Otsu, Satoshi;
- Arima, Shiho;
- Fukahori, Masaru;
- Makiyama, Akitaka;
- Taguchi, Hiroki;
- Honda, Takuya;
- Mitsugi, Kenji;
- Nio, Kenta;
- Ide, Yasushi;
- Ureshino, Norio;
- Shirakawa, Tsuyoshi;
- Otsuka, Taiga
Publication type:
journal article
Multicenter Retrospective Analysis of Original versus Modified FOLFIRINOX in Metastatic Pancreatic Cancer: Results of the NAPOLEON Study.
Published in:
Oncology, 2023, v. 101, n. 1, p. 22, doi. 10.1159/000527176
By:
- Nakazawa, Junichi;
- Tsuruta, Nobuhiro;
- Shimokawa, Mototsugu;
- Kawahira, Machiko;
- Arima, Shiho;
- Ido, Akio;
- Koga, Futa;
- Ueda, Yujiro;
- Komori, Azusa;
- Otsu, Satoshi;
- Fukahori, Masaru;
- Makiyama, Akitaka;
- Taguchi, Hiroki;
- Honda, Takuya;
- Shibuki, Taro;
- Nio, Kenta;
- Ide, Yasushi;
- Ureshino, Norio;
- Mizuta, Toshihiko;
- Otsuka, Taiga
Publication type:
Article
Asunaprevir and daclatasvir in hemodialysis patients with chronic hepatitis C virus genotype 1b infection.
Published in:
JGH Open, 2017, v. 1, n. 4, p. 148, doi. 10.1002/jgh3.12026
By:
- Otsuka, Taiga;
- Kawaguchi, Yasunori;
- Mizuta, Toshihiko;
- Ide, Yasushi;
- Koga, Futa;
- Kumagai, Takanori;
- Yoshioka, Wataru;
- Murayama, Kenichiro;
- Rikitake, Osamu;
- Ikeda, Yuji;
- Ozaki, Iwata
Publication type:
Article
Author Correction: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.
Published in:
2024
By:
- Shirakawa, Tsuyoshi;
- Makiyama, Akitaka;
- Shimokawa, Mototsugu;
- Otsuka, Taiga;
- Shinohara, Yudai;
- Koga, Futa;
- Ueda, Yujiro;
- Nakazawa, Junichi;
- Otsu, Satoshi;
- Komori, Azusa;
- Arima, Shiho;
- Fukahori, Masaru;
- Taguchi, Hiroki;
- Honda, Takuya;
- Shibuki, Taro;
- Nio, Kenta;
- Ide, Yasushi;
- Ureshino, Norio;
- Mizuta, Toshihiko;
- Mitsugi, Kenji
Publication type:
Correction Notice
Efficacy of second-line chemotherapy after treatment with gemcitabine plus nab-paclitaxel or FOLFIRINOX in patients with metastatic pancreatic cancer.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-46924-0
By:
- Fukahori, Masaru;
- Okabe, Yoshinobu;
- Shimokawa, Mototsugu;
- Otsuka, Taiga;
- Koga, Futa;
- Ueda, Yujiro;
- Nakazawa, Junichi;
- Komori, Azusa;
- Otsu, Satoshi;
- Arima, Shiho;
- Makiyama, Akitaka;
- Taguchi, Hiroki;
- Honda, Takuya;
- Ushijima, Tomoyuki;
- Miwa, Keisuke;
- Shibuki, Taro;
- Nio, Kenta;
- Ide, Yasushi;
- Ureshino, Norio;
- Mizuta, Toshihiko
Publication type:
Article

Found: 13